GLIOBLASTOMA IS THE MOST COMMON AND MOST AGGRESSIVE TYPE OF BRAIN TUMOR. WITH AN INCIDENCE OF 3 CASES PER 100,000 PEOPLE IN NORTH AMERICA AND EUROPE, IT ACCOUNTS FOR HALF OF PRIMARY MALIGNAT BRAIN TUMERS. CANCER TREATMENT HAS MADE TREMENDOUS PROGRESS OVER THE PAST DECADE. HOWEVER THE PROGNOSIS FOR GLIOBLASTOMA REMAINS VERY POOR: WITH THE CURRENT STANDARD OF CARE, ONLY 10% OF PATIENTS ARE EXPECTED TO SURVIVE FIVE YEARS AFTER THEIR DIAGNOSIS. IT IS THEREFORE ESSENTIAL TO INCREASE RESEARCH EFFORTS SPECIFIC TO GLIOBLASTOMA AND TO PROVIDE NEW THERAPEUTIC APPROACHES.
Geographies
Not indicated
Dates
Jan 1, 2024 – Dec 31, 2024
Source
990
No causes provided
No populations provided
–
$834.5K
Severe Brain Injury Awareness
SEVERE BRAIN INJURIES CAN OCCUR AT ANY STAGE OF LIFE. THEY CAN BE CAUSED BY EXTERNAL EVENTS LIKE A MOTOR VEHICLE ACCIDENT, SPORTS ACTIVITY, OR INTERNAL EVENTS LIKE A STROKE OR HEART ATTACK. THANKS TO IMPROVED TREATMENT, THE RATE OF PATIENTS WHO SURVIVE AFTER SUFFERING SEVERE BRAIN INJURIES IS INCREASING. WHILE SOME OF THESE PATIENTS REGAIN FULL CONSCIOUSNESS AFTER A TRANSIENT STATE OF COMA, OTHERS MAY DEVELOP MORE COMPLEX AND LASTING DISORDERS OF CONSCIOUSNESS AND BE BEHAVIORALLY UNRESPONSIVE EVEN THOUGH THEY OPEN THEIR EYES OR SHOW VERY MINIMAL, HARD TO DETECT, SIGNS OF CONSCIOUSNESS. THE IMPORTANCE OF ACCURACY IN SUCH A DIAGNOSIS CANNOT BE OVERSTATED: IT GUIDES TREATMENT ALLOCATION AND COULD MAKE THE DIFFERENCE BETWEEN AN END-OF-LIFE DECISION OR A SUSTAINED INTENSIVE CARE.